Effects of propranolol on the lipid pattern and post-prandial lipemia in patients with essential arterial hypertension
Ambrosio, G.B.; Donadon, W.; Pagnan, A.; Zamboni, S.; Dal Palù, C.
La Clinica Terapeutica 91(6): 565-573
1979
ISSN/ISBN: 0009-9074 PMID: 544160 Document Number: 146302
Document emailed within 1 workday
Related Documents
Santucci, A.; Aguglia, F.; Caputo, V.; De Mattia, G.; Cicconetti, P.; Balsano, F. 1978: Essential hypertension with low plasmatic renin activity (PRA). Effects of propranolol on arterial pressure and reninemia Bollettino Della Societa Italiana di Cardiologia 23(8): 1349-1355Mauro, B.; Savagnone, E. 1979: The combination of propranolol, hydrochlorothiazide and spironolactone in the treatment of essential arterial hypertension Bollettino Della Societa Italiana di Cardiologia 24(2): 189-196
Glezer, G.A.; Moskalenko, N.P.; Megrelishvili, R.I.; Zilbert, N.L. 1976: Effects of propranolol on haemodynamic changes and gas exchange at rest, in orthostasis, and on exercise in patients with arterial hypertension Cor et Vasa 18(1): 26-41
Sriram, U. 2001: Post-prandial hyperglycemia and its implications in pregnancy and lipid abnormalities Journal of the Association of Physicians of India 49(Special Issue): 22-24
De Ferrari, G.; Gaiter, A.; Ginevri, F.; Tizianello, A. 1979: Effects of pindolol on arterial pressure and plasma renin activity in essential hypertension and in hypertension during chronic renal insufficiency La Clinica Terapeutica 90(5): 461-468
Kristensen, B.O. 1977: Propranolol induced increase in serum thyroxine (total T-4) in patients with essential hypertension Ugeskrift for Laeger 139(1): 18-19
Siurin, S.A. 1997: Effects of essential oil on lipid peroxidation and lipid metabolism in patients with chronic bronchitis Klinicheskaia Meditsina 75(10): 43-45
Halawa, B. 1984: Effectiveness of propranolol in the treatment of arterial hypertension in elderly patients Przeglad Lekarski 41(8): 545-550
Sokolova, L.A.; Bondarenko, B.B.; Evdokimova, T.A. 1992: Comparative evaluation of cardiovascular system reactivity in patients with borderline arterial hypertension and the early stages of essential hypertension Fiziologiia Cheloveka 18(1): 128-135
Maggiore, Q.; Biagini, M.; Zoccali, C.; Misefari, M. 1975: Propranolol treatment of resistant arterial hypertension in patients on chronic dialysis Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 11: 222-228
Pellegrino, L.; Prencipe, G. 1995: Ultrasonography of the carotid arteries in mild-to-moderate essential arterial hypertension and isolated systolic arterial hypertension Cardiologia 40(2): 109-116
Metelitsa, V.I.; Filatova, N.P. 1991: The results of the comparative study of nadolol, propranolol, prazosin and hydrochlorothiazide in patients with arterial hypertension in a 12-month stepped-plan treatment (cooperative research). The Working Group of the Cooperative Program to Study New Preparations in the Prevention of Arterial Hypertension. I. The research protocol and results of monotherapy Terapevticheskii Arkhiv 63(8): 30-34
Conte, G.; Semplicini, A.; Rossi, G.P.; Calzavara, A. 1980: Effects of sodium depletion on urinary acid excretion in essential arterial hypertension Giornale di Clinica Medica 61(7): 517-524
Hergueta García de Guadiana, G.; Paumard Fraguas, A. 1989: Effects of a calcium antagonist, verapamil, on mild-moderate essential arterial hypertension Anales de Medicina Interna 6(1): 15-18
Uza, G. 1990: Hypophosphatemia in patients with essential arterial hypertension Journal of Trace Elements and Electrolytes in Health and Disease 4(4): 245-248
Wajngarten, M.; de Moraes, A.V.; Barretto, A.C.; Mady, C.; Martnelli Filho, M.; Dauar, D.; Netto, M.P.; Ebaid, M.; Décourt, L.V. 1980: Behavior of certain echocardiographic variables in patients with uncomplicated borderline arterial hypertension - influence of chlorthalidone and propranolol Revista do Hospital das Clinicas 35(4): 199-204
Cloix, J.F.; Devynck, M.A.; Meyer, P. 1982: Plasma protein changes in essential arterial hypertension: a new genetic marker for arterial hypertension? Annales de Pediatrie 29(9): 655-656
Vigna, G.B.; Donega, P.; Passaro, A.; Zanca, R.; Cattin, L.; Fonda, M.; Pauciullo, P.; Marotta, G.; Fellin, R.; Gasparrini, S.; Piliego, T. 1999: Post-prandial effects of gemfibrozil vs simvastatin in hypercholesterolemic subjects with borderline hypertriglyceridemia Nutrition Metabolism and Cardiovascular Diseases: Nmcd 9(5): 234-243
Hørlyck, K. 1980: Changes in glomerular filtration rate during long-term treatment with propranolol and peripheral vasodilators in patients with arterial hypertension Danish Medical Bulletin 27(3): 168
Planz, G.; Planz, R.; Gierlichs, H.W.; Rahn, K.H. 1978: Effect of the beta-receptor blocker propranolol on the catecholamin level and dopamin-beta-hydroxylase in patients with essential hypertension Die Medizinische Welt 29(9): 366-367